In the present study, we aimed to validate the single biomarkers CD44 rs8193 C>T, ALCAM rs1157 G>A and LGR5 rs17109924 T>C based on our preliminary findings in a large and independent study cohort of 742 stage II and III colon cancer patients. The gene discussed is CD44; the disease is colonic neoplasm.